CANCER STATISTICS

Column

Key statistics (Ovary etc., ICD-10: C48.1-2 (Serous), C56, C57.0-4)
Cancer incidence 2018–2022
Average number of new cases per year 587
Age-standardised incidence per 100 000 persons per year 18.5
Proportion of all cancers 3.4%
Risk of developing cancer during lifetime 1.7%
Average annual change in years 2013–2022 -0.8%
Cancer mortality 2018–2022
Average number of deaths per year 384
Age-standardised mortality per 100 000 persons per year 11.3
Proportion of all cancer deaths 6.3%
Risk of dying from cancer during lifetime 1.3%
Average annual change in years 2013–2022 -1.5%
Cancer prevalence at the end of 2022
Number of people living with cancer diagnosis 5823
Number of people living with cancer per 100 000 persons 207.2
Relative survival 2018–2022
One year after diagnosis 82%
Five years after diagnosis 48%

Column

Age-specific cancer incidence and mortality 2018–2022

Cancer incidence and mortality in 1953–2022 (age-standardised)

Cancer survival in 1958–2022 (age-standardised)

Column

How to interpret the table and figures? (Ovary etc.)

Cancer incidence in 2018–2022

  • On average 587 women were diagnosed with cancer each year
    • 3.4% of all new cancer cases in women
    • relative to population, 18.5 in 100,000 women were diagnosed with cancer each year (if the population’s age structure corresponded to Finland’s age structure in 2014).
  • The risk of developing cancer was highest in women aged 75-79 years (see top figure)
    • 63 in 100,000 women developed cancer each year
  • 1.7% of women develop cancer during their lifetime. This calculated estimate is based on the cancer incidence in 2018–2022.
  • Over the last ten years, 2013–2022, the average risk of cancer
    • did not change statistically significantly

Cancer mortality in 2018–2022

  • On average, 384 women died from cancer each year
    • 6.3% of all cancer deaths in women
  • The risk of dying from cancer was highest in women aged 80-84 years (see top figure)
    • 62 in 100,000 women died from cancer each year
  • 1.3% of women die from cancer during their lifetime. This calculated estimate is based on the cancer mortality in 2018–2022.
  • Over the last ten years, 2013–2022, the average risk of dying from cancer
    • decreased by 1.5% per year in women

Number of people living with breast cancer at the end of 2022

  • 5823 women diagnosed with cancer were alive
    • 0.2% of women in Finland

Patient survival in 2018–2022

  • The average survival of patients was
    • 82% one year after diagnosis
    • 48% five years after diagnosis

Learn more about cancer diseases on the website All about cancer.

CONCEPTS

Column

Terms and definitions used in the cancer statistics
Cancer incidence The number of new cancer cases over a specific period of time (e.g. one calendar year) in the population. The incidence ratio is the number of cases per 100,000 persons per year. It is the number of new cases age-standardised to Finland’s age structure in 2014, i.e. in relation to the population, if the age structure of the population corresponded to the age structure in Finland in 2014. Gender differences or temporal changes in the age structure do not influence age-standardised incidence.
Cancer mortality The number of deaths attributable to cancer over a specific period of time in the population. The mortality ratio is the number of deaths per 100,000 persons per year. It is the number of cancer deaths age-standardised to Finland’s age structure in 2014, i.e. in relation to the population, if the age structure of the population corresponded to the age structure in Finland in 2014. Gender differences or temporal changes in the age structure do not influence age-standardised mortality.
Ten-year development in incidence and mortality Changes in the incidence and mortality of cancer were examined by comparing the average incidence and mortality rates per age group over the last ten years. The change percentage describes the average annual change in incidence and mortality rates per age group relative to the population. For example, a change percentage in incidence of +2% means an annual increase of 2 per cent, whereas –2% means an annual decrease of 2 per cent in age-standardised incidence.
People living with cancer (prevalence) The number of people living with cancer in the population at the end of 2022. The prevalence proportion is the corresponding number in relation to the population.
Patient survival The average survival of patients is measured by a relative survival ratio. It is an estimate of the proportion of patients who are alive after a certain period of time after diagnosis, if the cancer were the only factor affecting the mortality. The time series for patient survival has been age-standardised to the age distribution of patients diagnosed in Finland between 2018 and 2022, so that changes in the age structure do not affect the time series.